loadpatents
Patent applications and USPTO patent grants for Dymock; Brian William.The latest application filed is for "lsoxazole compounds".
Patent | Date |
---|---|
Isoxazole compounds as inhibitors of heat shock proteins Grant 11,234,987 - Drysdale , et al. February 1, 2 | 2022-02-01 |
lsoxazole Compounds App 20190358241 - Drysdale; Martin James ;   et al. | 2019-11-28 |
Isoxazole compounds as inhibitors of heat shock proteins Grant 10,413,550 - Drysdale , et al. Sept | 2019-09-17 |
Selective anti-cancer compounds Grant 10,308,631 - Lee , et al. | 2019-06-04 |
Selective Anti-cancer Compounds App 20180179178 - LEE; Sang Hyun ;   et al. | 2018-06-28 |
Isoxazole Compounds As Inhibitors Of Heat Shock Proteins App 20170326152 - Drysdale; Martin James ;   et al. | 2017-11-16 |
Isoxazole compounds as inhibitors of heat shock proteins Grant 9,718,793 - Drysdale , et al. August 1, 2 | 2017-08-01 |
Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors Grant 8,642,594 - Dymock , et al. February 4, 2 | 2014-02-04 |
Isoxazole Compounds As Inhibitors Of Heat Shock Proteins App 20130289026 - Drysdale; Martin James ;   et al. | 2013-10-31 |
Isoxazole compounds as inhibitors of heat shock proteins Grant 8,507,480 - Drysdale , et al. August 13, 2 | 2013-08-13 |
Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-iso-propyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-i- soxazole-3-carboxylic acid ethylamide and formulations comprising these forms Grant 8,487,095 - Drysdale , et al. July 16, 2 | 2013-07-16 |
Isoxazole compounds as inhibitors of heat shock proteins Grant 8,450,310 - Drysdale , et al. May 28, 2 | 2013-05-28 |
Isoxazole Compounds As Inhibitors Of Heat Shock Proteins App 20120252797 - Drysdale; Martin James ;   et al. | 2012-10-04 |
Acid Addition Salts, Hydrates And Polymorphs Of 5-(2,4-dihydroxy-5-iso-propyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-i- Soxazole-3-carboxylic Acid Ethylamide And Formulations Comprosing These Forms App 20120172592 - Drysdale; Martin James ;   et al. | 2012-07-05 |
Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-is- oxazole-3-carboxylic acid ethylamide and formulations comprising these forms Grant 8,163,747 - Drysdale , et al. April 24, 2 | 2012-04-24 |
Pyridothiophene Compounds App 20110034457 - Drysdale; Martin James ;   et al. | 2011-02-10 |
Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors Grant 7,820,658 - Dymock , et al. October 26, 2 | 2010-10-26 |
3-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitors for the treatment of cancer Grant 7,803,831 - Beswick , et al. September 28, 2 | 2010-09-28 |
Isozazole Compounds As Inhibitors Of Heat Shock Proteins App 20100179138 - Drysdale; Martin James ;   et al. | 2010-07-15 |
Substituted 5-membered ring compounds and their use Grant 7,728,016 - Cheung , et al. June 1, 2 | 2010-06-01 |
Pyrimidothiophene Compounds App 20100120767 - Dymock; Brian William ;   et al. | 2010-05-13 |
Isoxazole compounds as inhibitors of heat shock proteins Grant 7,705,027 - Drysdale , et al. April 27, 2 | 2010-04-27 |
Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-is- oxazole-3-carboxylic Acid Ethylamide and Formulations Comprising These Forms App 20100093732 - Drysdale; Martin James ;   et al. | 2010-04-15 |
Pyrazole compounds as HSP90 inhibitors for the treatment of cancer Grant 7,632,855 - Barrilalonso , et al. December 15, 2 | 2009-12-15 |
Pyrazole compounds Grant 7,612,201 - Beswick , et al. November 3, 2 | 2009-11-03 |
Pyrimidothiophene Compounds App 20090069336 - Barril-Alonso; Xavier ;   et al. | 2009-03-12 |
Pyridothiophene Compounds App 20070213328 - Drysdale; Martin James ;   et al. | 2007-09-13 |
3,4-diarylpyrazoles and their use in the therapy of cancer Grant 7,247,734 - Drysdale , et al. July 24, 2 | 2007-07-24 |
3-(2-Hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer App 20070112192 - Beswick; Mandy Christine ;   et al. | 2007-05-17 |
Pyrazole compounds as hsp90 inhibitors for the treatment of cancer App 20070072855 - Barrilalonso; Xavier ;   et al. | 2007-03-29 |
Non-nucleoside reverse transcriptase inhibitors Grant 7,189,718 - Dunn , et al. March 13, 2 | 2007-03-13 |
Anti-HIV pyrazole derivatives Grant 7,183,296 - Dymock , et al. February 27, 2 | 2007-02-27 |
Pyrimidothiophene compounds App 20070043044 - Dymock; Brian William ;   et al. | 2007-02-22 |
Isoxazole compounds as inhibitors of heat shock proteins App 20060241106 - Drysdale; Martin James ;   et al. | 2006-10-26 |
Substituted 5-membered ring compounds and their use App 20060235058 - Cheung; Kwai Ming ;   et al. | 2006-10-19 |
Pyrazole compounds App 20060148817 - Beswick; Christine ;   et al. | 2006-07-06 |
3,4-diarylpyrazoles and their use in the therapy of cancer App 20050222230 - Drysdale, Martin James ;   et al. | 2005-10-06 |
Non-nucleoside reverse transcriptase inhibitors App 20040198736 - Dunn, James Patrick ;   et al. | 2004-10-07 |
Anti-HIV pyrazole derivatives App 20040192752 - Dymock, Brian William ;   et al. | 2004-09-30 |
Anti-HCV nucleoside derivatives App 20040110718 - Devos, Rene ;   et al. | 2004-06-10 |
Pyrrole derivatives Grant 6,737,429 - Dymock , et al. May 18, 2 | 2004-05-18 |
Anti-HIV pyrazole derivatives Grant 6,699,887 - Dymock , et al. March 2, 2 | 2004-03-02 |
Anti-HIV pyrazole derivatives App 20030018197 - Dymock, Brian William ;   et al. | 2003-01-23 |
Anti-HCV nucleoside derivatives App 20030008841 - Devos, Rene ;   et al. | 2003-01-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.